logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Assessing And Improving Value In Cancer Care Workshop Summary 1st Edition Institute Of Medicine

  • SKU: BELL-2426626
Assessing And Improving Value In Cancer Care Workshop Summary 1st Edition Institute Of Medicine
$ 31.00 $ 45.00 (-31%)

4.3

18 reviews

Assessing And Improving Value In Cancer Care Workshop Summary 1st Edition Institute Of Medicine instant download after payment.

Publisher: National Academies Press
File Extension: PDF
File size: 3.72 MB
Pages: 165
Author: Institute of Medicine
ISBN: 9780309138147, 0309138140
Language: English
Year: 2009
Edition: 1

Product desciption

Assessing And Improving Value In Cancer Care Workshop Summary 1st Edition Institute Of Medicine by Institute Of Medicine 9780309138147, 0309138140 instant download after payment.

Unlike many other areas in health care, the practice of oncology presents unique challenges that make assessing and improving value especially complex. First, patients and professionals feel a well-justified sense of urgency to treat for cure, and if cure is not possible, to extend life and reduce the burden of disease. Second, treatments are often both life sparing and highly toxic. Third, distinctive payment structures for cancer medicines are intertwined with practice. Fourth, providers often face tremendous pressure to apply the newest technologies to patients who fail to respond to established treatments, even when the evidence supporting those technologies is incomplete or uncertain, and providers may be reluctant to stop toxic treatments and move to palliation, even at the end of life. Finally, the newest and most novel treatments in oncology are among the most costly in medicine. This volume summarizes the results of a workshop that addressed these issues from multiple perspectives, including those of patients and patient advocates, providers, insurers, health care researchers, federal agencies, and industry. Its broad goal was to describe value in oncology in a complete and nuanced way, to better inform decisions regarding developing, evaluating, prescribing, and paying for cancer therapeutics.

Related Products